The Nocturia market is segmented by the indication that is Mixed nocturia, Low nocturnal bladder capacity, Nocturnal polyuria, Global polyuria, and by drug type that are Anticholinergic drugs, Desmopressin, Antibiotics, Antispasmodic.
Industry: Healthcare
Published Date: December-2017
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 192
Report ID: PMRREP20806
1. Global Outlook
2. Global Nocturia Market - Executive Summary
3. Global Nocturia Market Overview
3.1. Introduction
3.1.1. Global Nocturia Market Taxonomy
3.1.2. Global Nocturia Market Definition
3.2. Global Nocturia Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Nocturia Market Y-o-Y Growth
3.3. Global Nocturia Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Trends
3.4. Supply Chain
3.5. Cost Structure
3.6. Key Participants Market Presence (Intensity Map) By Region
3.7. Product Life Cycle Nocturia Market
3.8. List of Distributors
3.9. Key Regulations
3.9.1. U.S.
3.9.2. Canada
3.9.3. Europe
4. Global Nocturia Market Analysis and Forecast 2012-2026
4.1. Global Nocturia Market Size and Forecast By Indication, 2012-2026
4.1.1. Mixed Nocturia Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Low Nocturnal Bladder Capacity Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Nocturnal Polyuria Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Global Polyuria Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.2. Global Nocturia Market Size and Forecast By Drug Type, 2012-2026
4.2.1. Anticholinergic Drugs Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Desmopressin Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Antibiotics Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.2.4. Antispasmodic Market Size and Forecast, 2012-2026
4.2.4.1. Revenue (US$ Mn) Comparison, By Region
4.2.4.2. Market Share Comparison, By Region
4.2.4.3. Y-o-Y growth Comparison, By Region
4.2.5. Other Drugs Market Size and Forecast, 2012-2026
4.2.5.1. Revenue (US$ Mn) Comparison, By Region
4.2.5.2. Market Share Comparison, By Region
4.2.5.3. Y-o-Y growth Comparison, By Region
4.3. Global Nocturia Market Size and Forecast By Distribution Channel, 2012-2026
4.3.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Retail Pharmacies Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Drug Stores Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
4.3.4. Online Pharmacies Market Size and Forecast, 2012-2026
4.3.4.1. Revenue (US$ Mn) Comparison, By Region
4.3.4.2. Market Share Comparison, By Region
4.3.4.3. Y-o-Y growth Comparison, By Region
5. North America Nocturia Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Indication
5.6. Revenue (US$ Mn) Comparison, By Drug Type
5.7. Revenue (US$ Mn) Comparison, By Distribution Channel
6. Latin America Nocturia Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Indication
6.6. Revenue (US$ Mn) Comparison, By Drug Type
6.7. Revenue (US$ Mn) Comparison, By Distribution Channel
7. Europe Nocturia Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. U.K Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Indication
7.6. Revenue (US$ Mn) Comparison, By Drug Type
7.7. Revenue (US$ Mn) Comparison, By Distribution Channel
8. APEJ Nocturia Market Size and Forecast, 2012-2026
8.1. APEJ Outlook
8.2. APEJ Parent Market Outlook
8.3. APEJ Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
8.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
8.4.3. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.4.4. ASEAN Market Size and Forecast (US$ Mn), 2012-2026
8.4.5. Australia & New Zealand Market Size and Forecast (US$ Mn), 2012-2026
8.4.6. Rest of Asia Pacific Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Indication
8.6. Revenue (US$ Mn) Comparison, By Drug Type
8.7. Revenue (US$ Mn) Comparison, By Distribution Channel
9. MEA Nocturia Market Size and Forecast, 2012-2026
9.1. MEA Outlook
9.2. MEA Parent Market Outlook
9.3. MEA Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Indication
9.6. Revenue (US$ Mn) Comparison, By Drug Type
9.7. Revenue (US$ Mn) Comparison, By Distribution Channel
10. Global Nocturia Market Company Share, Competition Landscape and Company Profiles
10.1. Competition Landscape
10.2. Company Profiles
10.2.1. Allergan, Inc.
10.2.2. Urigen Pharmaceuticals
10.2.3. Ferring Pharmaceuticals
10.2.4. Glenmark Pharmaceuticals Inc.
10.2.5. Teva Pharmaceutical Industries Ltd.
10.2.6. AA Pharma Inc.
10.2.7. Avadel Pharmaceuticals plc
11. Research Methodology
12. Disclaimer
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
TABLE 1: Global Nocturia Market Value (US$ Mn), 2012-2017
TABLE 2: Global Nocturia Market Value (US$ Mn), 2018-2026
TABLE 3: Global Nocturia Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4: Global Mixed Nocturia Segment Value (US$ Mn), By Region 2012-2017
TABLE 5: Global Mixed Nocturia Segment Value (US$ Mn), By Region 2018-2026
TABLE 6: Global Mixed Nocturia Segment Market Share, By Region 2012-2017
TABLE 7: Global Mixed Nocturia Segment Market Share, By Region 2018-2026
TABLE 8: Global Mixed Nocturia Segment Y-o-Y, By Region 2017-2026
TABLE 9: Global Low Nocturnal Bladder Capacity Segment Value (US$ Mn), By Region 2012-2017
TABLE 10: Global Low Nocturnal Bladder Capacity Segment Value (US$ Mn), By Region 2018-2026
TABLE 11: Global Low Nocturnal Bladder Capacity Segment Market Share, By Region 2012-2017
TABLE 12: Global Low Nocturnal Bladder Capacity Segment Market Share, By Region 2018-2026
TABLE 13: Global Low Nocturnal Bladder Capacity Segment Y-o-Y, By Region 2017-2026
TABLE 14: Global Nocturnal Polyuria Segment Value (US$ Mn), By Region 2012-2017
TABLE 15: Global Nocturnal Polyuria Segment Value (US$ Mn), By Region 2018-2026
TABLE 16: Global Nocturnal Polyuria Segment Market Share, By Region 2012-2017
TABLE 17: Global Nocturnal Polyuria Segment Market Share, By Region 2018-2026
TABLE 18: Global Nocturnal Polyuria Segment Y-o-Y, By Region 2017-2026
TABLE 19: Global Polyuria Segment Value (US$ Mn), By Region 2012-2017
TABLE 20: Global Polyuria Segment Value (US$ Mn), By Region 2018-2026
TABLE 21: Global Polyuria Segment Market Share, By Region 2012-2017
TABLE 22: Global Polyuria Segment Market Share, By Region 2018-2026
TABLE 23: Global Polyuria Segment Y-o-Y, By Region 2017-2026
TABLE 24: Global Anticholinergic Drugs Segment Value (US$ Mn), By Region 2012-2017
TABLE 25: Global Anticholinergic Drugs Segment Value (US$ Mn), By Region 2018-2026
TABLE 26: Global Anticholinergic Drugs Segment Market Share, By Region 2012-2017
TABLE 27: Global Anticholinergic Drugs Segment Market Share, By Region 2018-2026
TABLE 28: Global Anticholinergic Drugs Segment Y-o-Y, By Region 2017-2026
TABLE 29: Global Desmopressin Segment Value (US$ Mn), By Region 2012-2017
TABLE 30: Global Desmopressin Segment Value (US$ Mn), By Region 2018-2026
TABLE 31: Global Desmopressin Segment Market Share, By Region 2012-2017
TABLE 32: Global Desmopressin Segment Market Share, By Region 2018-2026
TABLE 33: Global Desmopressin Segment Y-o-Y, By Region 2017-2026
TABLE 34: Global Antibiotics Segment Value (US$ Mn), By Region 2012-2017
TABLE 35: Global Antibiotics Segment Value (US$ Mn), By Region 2018-2026
TABLE 36: Global Antibiotics Segment Market Share, By Region 2012-2017
TABLE 37: Global Antibiotics Segment Market Share, By Region 2018-2026
TABLE 38: Global Antibiotics Segment Y-o-Y, By Region 2017-2026
TABLE 39: Global Antispasmodic Segment Value (US$ Mn), By Region 2012-2017
TABLE 40: Global Antispasmodic Segment Value (US$ Mn), By Region 2018-2026
TABLE 41: Global Antispasmodic Segment Market Share, By Region 2012-2017
TABLE 42: Global Antispasmodic Segment Market Share, By Region 2018-2026
TABLE 43: Global Antispasmodic Segment Y-o-Y, By Region 2017-2026
TABLE 44: Global Other Drugs Segment Value (US$ Mn), By Region 2012-2017
TABLE 45: Global Other Drugs Segment Value (US$ Mn), By Region 2018-2026
TABLE 46: Global Other Drugs Segment Market Share, By Region 2012-2017
TABLE 47: Global Other Drugs Segment Market Share, By Region 2018-2026
TABLE 48: Global Other Drugs Segment Y-o-Y, By Region 2017-2026
TABLE 49: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 50: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 51: Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 52: Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 53: Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 54: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 55: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 56: Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 57: Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 58: Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 59: Global Drug Stores Segment Value (US$ Mn), By Region 2012-2017
TABLE 60: Global Drug Stores Segment Value (US$ Mn), By Region 2018-2026
TABLE 61: Global Drug Stores Segment Market Share, By Region 2012-2017
TABLE 62: Global Drug Stores Segment Market Share, By Region 2018-2026
TABLE 63: Global Drug Stores Segment Y-o-Y, By Region 2017-2026
TABLE 64: Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 65: Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 66: Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 67: Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 68: Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 69: North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 70: North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 71: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 72: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 73: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 74: North America Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 75: North America Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 76: North America Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 77: North America Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 78: North America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 79: North America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 80: North America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 81: North America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 82: Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 83: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 84: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 85: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 86: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 87: Latin America Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 88: Latin America Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 89: Latin America Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 90: Latin America Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 91: Latin America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 92: Latin America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 93: Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 94: Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 95: Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 96: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 97: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 98: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 99: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 100: Europe Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 101: Europe Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 102: Europe Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 103: Europe Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 104: Europe Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 105: Europe Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 106: Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 107: Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 108: APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 109: APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 110: APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 111: APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 112: APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 113: APEJ Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 114: APEJ Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 115: APEJ Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 116: APEJ Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 117: APEJ Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 118: APEJ Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 119: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 120: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 121: MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 122: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 123: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 124: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 125: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 126: MEA Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 127: MEA Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 128: MEA Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 129: MEA Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 130: MEA Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 131: MEA Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 132: MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 133: MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
FIG. 1: Global Nocturia Market Value (US$ Mn), 2012-2017
FIG. 2: Global Nocturia Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3: Global Nocturia Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4: Global Mixed Nocturia Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5: Global Mixed Nocturia Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6: Global Mixed Nocturia Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7: Global Low Nocturnal Bladder Capacity Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8: Global Low Nocturnal Bladder Capacity Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9: Global Low Nocturnal Bladder Capacity Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10: Global Nocturnal Polyuria Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11: Global Nocturnal Polyuria Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12: Global Nocturnal Polyuria Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13: Global Polyuria Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14: Global Polyuria Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15: Global Polyuria Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16: Global Anticholinergic Drugs Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17: Global Anticholinergic Drugs Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18: Global Anticholinergic Drugs Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19: Global Desmopressin Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20: Global Desmopressin Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21: Global Desmopressin Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22: Global Antibiotics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23: Global Antibiotics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24: Global Antibiotics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25: Global Antispasmodic Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26: Global Antispasmodic Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27: Global Antispasmodic Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28: Global Other Drugs Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29: Global Other Drugs Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30: Global Other Drugs Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33: Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36: Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37: Global Drug Stores Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38: Global Drug Stores Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39: Global Drug Stores Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42: Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43: North America Nocturia Market Value (US$ Mn), By Country 2012-2017
FIG. 44: North America Nocturia Market Value (US$ Mn), By Country 2018-2026
FIG. 45: North America Nocturia Market Value (US$ Mn), By Indication 2012-2017
FIG. 46: North America Nocturia Market Value (US$ Mn), By Indication 2018-2026
FIG. 47: North America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 48: North America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 49: North America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 50: North America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 51: Latin America Nocturia Market Value (US$ Mn), By Country 2012-2017
FIG. 52: Latin America Nocturia Market Value (US$ Mn), By Country 2018-2026
FIG. 53: Latin America Nocturia Market Value (US$ Mn), By Indication 2012-2017
FIG. 54: Latin America Nocturia Market Value (US$ Mn), By Indication 2018-2026
FIG. 55: Latin America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 56: Latin America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 57: Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 58: Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 59: Europe Nocturia Market Value (US$ Mn), By Country 2012-2017
FIG. 60: Europe Nocturia Market Value (US$ Mn), By Country 2018-2026
FIG. 61: Europe Nocturia Market Value (US$ Mn), By Indication 2012-2017
FIG. 62: Europe Nocturia Market Value (US$ Mn), By Indication 2018-2026
FIG. 63: Europe Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 64: Europe Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 65: Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 66: Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 67: APEJ Nocturia Market Value (US$ Mn), By Country 2012-2017
FIG. 68: APEJ Nocturia Market Value (US$ Mn), By Country 2018-2026
FIG. 69: APEJ Nocturia Market Value (US$ Mn), By Indication 2012-2017
FIG. 70: APEJ Nocturia Market Value (US$ Mn), By Indication 2018-2026
FIG. 71: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 72: APEJ Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 73: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 74: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 75: MEA Nocturia Market Value (US$ Mn), By Country 2012-2017
FIG. 76: MEA Nocturia Market Value (US$ Mn), By Country 2018-2026
FIG. 77: MEA Nocturia Market Value (US$ Mn), By Indication 2012-2017
FIG. 78: MEA Nocturia Market Value (US$ Mn), By Indication 2018-2026
FIG. 79: MEA Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 80: MEA Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 81: MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 82: MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
